Us Bancorp \De\ 2seventy Bio, Inc. Transaction History

Us Bancorp \De\

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$3.6 - $5.79 $360 - $579	100 New	100 $0
Q3 2023 Nov 03, 2023	SELL	$3.14 - $11.2 $395 - $1,411	-126 Reduced 4.98%	2,402 $9,000
Q2 2023 Aug 09, 2023	BUY	$8.45 - $12.48 $18,860 - $27,855	2,232 Added 754.05%	2,528 $25,000
Q1 2023 May 09, 2023	BUY	$9.21 - $14.98 $257 - $419	28 Added 10.45%	296 $3,000
Q4 2022 Feb 13, 2023	SELL	$8.57 - $17.0 $719 - $1,428	-84 Reduced 23.86%	268 $2,000
Q3 2022 Oct 27, 2022	SELL	$12.56 - $17.54 $3,994 - $5,577	-318 Reduced 47.46%	352 $5,000
Q2 2022 Aug 01, 2022	BUY	$10.55 - $18.81 $1,624 - $2,896	154 Added 29.84%	670 $9,000
Q1 2022 May 11, 2022	BUY	$11.67 - $26.72 $1,178 - $2,698	101 Added 24.34%	516 $9,000
Q4 2021 Feb 11, 2022	BUY	$13.77 - $42.56 $5,714 - $17,662	415 New	415 $11,000

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $137M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.